Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.
about
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cellsCo-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.
P2860
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Epigenetics in acute promyeloc ...... nsition to targeted therapies.
@en
type
label
Epigenetics in acute promyeloc ...... nsition to targeted therapies.
@en
prefLabel
Epigenetics in acute promyeloc ...... nsition to targeted therapies.
@en
P2093
P2860
P921
P356
P1476
Epigenetics in acute promyeloc ...... nsition to targeted therapies.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.374
P407
P5008
P577
2014-09-23T00:00:00Z
2015-02-03T00:00:00Z
P5875
P6179
1008829436